Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8IDN

Cryo-EM structure of RBD/E77-Fab complex

8IDN の概要
エントリーDOI10.2210/pdb8idn/pdb
EMDBエントリー35369
分子名称Spike protein S1, E77 Fab heavy chain, E77 Fab light chain, ... (4 entities in total)
機能のキーワードrbd, antibody, complex, viral protein/immune system, viral protein-immune system complex
由来する生物種Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
詳細
タンパク質・核酸の鎖数3
化学式量合計74398.44
構造登録者
Lu, D.F.,Zhang, Z.C. (登録日: 2023-02-13, 公開日: 2023-06-21, 最終更新日: 2025-07-23)
主引用文献Zhang, Z.,Li, X.,Xue, Y.,Yang, B.,Jia, Y.,Liu, S.,Lu, D.
The structure of the RBD-E77 Fab complex reveals neutralization and immune escape of SARS-CoV-2.
Acta Crystallogr D Struct Biol, 79:746-757, 2023
Cited by
PubMed Abstract: The spike protein (S) of SARS-CoV-2 is the major target of neutralizing antibodies and vaccines. Antibodies that target the receptor-binding domain (RBD) of S have high potency in preventing viral infection. The ongoing evolution of SARS-CoV-2, especially mutations occurring in the RBD of new variants, has severely challenged the development of neutralizing antibodies and vaccines. Here, a murine monoclonal antibody (mAb) designated E77 is reported which engages the prototype RBD with high affinity and potently neutralizes SARS-CoV-2 pseudoviruses. However, the capability of E77 to bind RBDs vanishes upon encountering variants of concern (VOCs) which carry the N501Y mutation, such as Alpha, Beta, Gamma and Omicron, in contrast to its performance with the Delta variant. To explain the discrepancy, cryo-electron microscopy was used to analyze the structure of an RBD-E77 Fab complex, which reveals that the binding site of E77 on RBD belongs to the RBD-1 epitope, which largely overlaps with the binding site of human angiotensin-converting enzyme 2 (hACE2). Both the heavy chain and the light chain of E77 interact extensively with RBD and contribute to the strong binding of RBD. E77 employs CDRL1 to engage Asn501 of RBD and the Asn-to-Tyr mutation could generate steric hindrance, abolishing the binding. In sum, the data provide the landscape for an in-depth understanding of immune escape of VOCs and rational antibody engineering against emerging variants of SARS-CoV-2.
PubMed: 37428848
DOI: 10.1107/S2059798323005041
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.35 Å)
構造検証レポート
Validation report summary of 8idn
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon